It was looking like a brilliant week, with nearly everything in the black, until Friday when nearly everything went into the red. However, a socking great rise in JLP:Jubilee Metals meant the deficit between cost and value narrowed by £4,225 to £140,941 and the deficit between injection and value reduced to £58,997, with total portfolio value increasing to £120,871.
Worst performer was EDV:Endeavour Mining which dropped 7% despite gold hardly dropping at all. These are barely in profit, which is a worry if gold has peaked. I'm hoping they will announce big profits and start paying a dividend, which should lead to a re-rate.
TLOU:Tlou Energy dropped 6% but there's nothing unusual in that.
ALU:Alumasc Group has been dropping quite badly over the last few months, but recovered 6% this week to go 25% up.
YU.:Yu Group also rose 6% and are almost in profit.
IES:Invinity Energy announced some new contracts and went up 8%, so my recent purchase is only 10% down but my main holding is 89% down.
AMRQ:Amaroq went up a healthy 10% to go 27% up, but I'm getting increasingly nervous about the intentions of America towards Greenland, and I'm not sure I'm prepared to risk the same fate as POLY:Polymetal and FXP:Ferrexpo which lost almost everything when Putin invaded Ukraine, as I can see similar happening to AMRQ. I might sell the ones in my SIPP but keep the ones in my ISA because they have massive potential if Greenland is left alone.
JLP:Jubilee Metals announced the completion of the sale of South African assets, which was a relief as I was concerned something would mess that up. However now they are certain of the cash, I'm hoping it won't be long before announcements of new tailings purchases. My holdings are still around 50% down, so a long way to break even.
Share of the week is SBTX:SkinBioTherapeutics which went up 18%. I think the recent drops were caused by some big sellers, so hopefully now they have gone, potential investors are considering the potential of the new compound going into products and revenue coming in.
Here's the ISA and shares portfolio after week 23 of year 11.
| Weekly Change | |||
| Cash | £99.03 | -£78.09 | |
| Portfolio cost | £116,875.69 | +£117.60 | |
| Portfolio sell value (bid price-commission) | £37,547.76 | (-67.9%) | +£2,991.04 |
| Potential profits | £390.23 | +£150.78 | |
| Yr 11 Dividends | £69.36 | +£0 | |
| Yr 11 Interest | £0.76 | +£0.01 | |
| Yr 11 Profit from sales | £527.06 | +£39.50 | |
| Yr 11 proj avg monthly profit | £105.06 | (1.4%) | +£3.01 |
| Total Dividends | £12,557.43 | +£0 | |
| Total Interest | £9.33 | +£0.01 | |
| Total Profit from sales | £18,087.33 | +£39.50 | |
| Average monthly cash profit | £239.80 | (3.3%) | -£0.12 |
| (Sold stocks profit + Dividends - Fees / Months) |
I looked at the price of CWR:Ceres Power and noticed it had dropped back below the price I bought it before selling for a profit. It appears to have been the victim of a bear attack from someone presumably shorting the shares. They've engineered a 50% drop in price, so I think now would be a good time to buy back.
I sacrificed my holding in BOKU:Boku as it wasn't really going anywhere. I may buy back if I make any profits elsewhere, but I thought there was a better potential in CWR. I sold my 495 shares in BOKU at 212p making £39.50 (3.9%) profit. Not a lot, but still a profit. I bought 538 shares in CWR at 206.681p costing £1,122.50. Happy to say they were up 3% on my purchase price and £19 in profit by the end of the week.
Value was up by almost £3,000 thanks to the big rises in JLP:Jubilee Metals and SBTX:SkinBioTherapeutics, and potential profits rose £150 mainly thanks to AMRQ:Amaroq.
The first time in a very, very long time we've had a good size tick upwards in one week.
Soaring above the trend line
Too small a profit to make any difference.
I had a £36 dividend from INVP:Investec, a more modest increase in value due to smaller holdings in JLP:Jubilee Metals and SBTX:SkinBioTherapeutics, and a decent increase in potential profits of £218 mainly thanks to ALU:Alumasc Group and AMRQ:Amaroq.
I like that graceful glide up towards the injection line.
Nicely above the trend line, but is it just a short-lived Santa Rally?
We're on the trend line. Selling my SIPP AMRQ:Amaroq should keep me above it next week.
The first time in a very, very long time we've had a good size tick upwards in one week.
Soaring above the trend line
Too small a profit to make any difference.
The SIPP looks like this after week 527 overall and week 7 of year 11.
| Weekly Change | ||||
| Cash | £1,034.82 | +£36.19 | ||
| Portfolio cost | £143,804.05 | +£0 | ||
| Portfolio sell value (bid price - commission) | £82,190.26 | (-42.8%) | +£1,234.65 | |
| Potential profits | £11,869.76 | +£218.91 | ||
| Yr 11 Dividends | £309.15 | +£36.05 | ||
| Yr 11 Interest | £0.14 | +£0.14 | ||
| Yr 11 Profit from sales | £800.74 | +£0 | ||
| Yr 11 proj avg monthly profit | £674.70 | (8.7%) | -£86.31 | |
| Total Dividends | £18,529.35 | +£36.05 | ||
| Total Interest | £20.84 | +£0.14 | ||
| Total Profit from sales | £25,467.25 | +£0 | ||
| Average monthly cash profit | £348.44 | (4.5%) | -£0.37 |
I had a £36 dividend from INVP:Investec, a more modest increase in value due to smaller holdings in JLP:Jubilee Metals and SBTX:SkinBioTherapeutics, and a decent increase in potential profits of £218 mainly thanks to ALU:Alumasc Group and AMRQ:Amaroq.
I like that graceful glide up towards the injection line.
Nicely above the trend line, but is it just a short-lived Santa Rally?
We're on the trend line. Selling my SIPP AMRQ:Amaroq should keep me above it next week.
I think I'm pretty much decided on selling my SIPP holding in AMRQ:Amaroq. It doesn't qualify as a SIPP holding because it doesn't pay dividends and isn't on my magic formula ranking. Selling at Friday's close price will get me £288 (17%) profit and liberate £1,929. It's in my Hargreaves Lansdown account, which is about to get £2,400 transfer from my pension and has £300 cash, so I'll have around £4,700 to invest in one go.
It's a shame HL doesn't allow regular investments from cash balance - it only allows them via direct debit, with the new injection invested each month. AJ Bell is much better as you can set up regular investments on the cash balance. When I sell an AJ Bell share, I leave it as cash so the regular investments have a pot to use.
I should really re-invest at least some of the proceeds in gold stocks, but there are few suitable candidates. CMCL:Caledonia Mining are 115th in my magic formula ranking and have always done badly for me. They are racking up big debt for a new mine and having to sell a load of gold using Zimbabwe currency so there are too many red flags. EDV:Endeavour Mining are 138th in my magic formula ranking, but they are massively increasing both production and free cash flow, reducing debt rapidly and paying dividends, so given my holding is only up 2% due to a recent pull-back, maybe I should put all AMRQ:Amaroq proceeds there.
Meanwhile I'll continue with my original plan to invest £1,100 in both HSX:Hiscox and MGNS:Morgan Sindall, and use the rest to increase my holding in BPM:BP Marsh & Partners. It's nice to have a plan!
No comments:
Post a Comment